molybdenum has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, PY; Su, CC; Yang, TH; Yen, HH | 1 |
| Krzymień, H | 1 |
2 other study(ies) available for molybdenum and Psoriasis
| Article | Year |
|---|---|
Tetrathiomolybdate, a copper chelator inhibited imiquimod-induced skin inflammation in mice.
Topics: Animals; Anti-Inflammatory Agents; Chelating Agents; Copper; Cytokines; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Imiquimod; Inflammation Mediators; Keratinocytes; Male; Mice, Inbred C57BL; Molybdenum; Phosphorylation; Psoriasis; Signal Transduction; Skin; Spleen; STAT3 Transcription Factor | 2018 |
[Attempts at treating rheumatoid arthritis and other chronic rheumatoid diseases with molybdenum compounds].
Topics: Arthritis; Arthritis, Rheumatoid; Chronic Disease; Copper; Female; Humans; Male; Molybdenum; Psoriasis; Quaternary Ammonium Compounds; Sjogren's Syndrome; Time Factors | 1970 |